Getagraph.com logo
NASDAQ Composite: ( -0.07%) 16 686
S&P 500 Futures
(0.08%) 5 331.25 points
Dow Jones Futures
(0.03%) 40 151 points
Nasdaq Futures
(0.14%) 18 661 points
Oil
(0.30%) $80.30
Gas
(1.75%) $2.67
Gold
(1.16%) $2 445.40
Silver
(2.43%) $32.02
Platinum
(-0.28%) $1 087.00
USD/EUR
(-0.01%) $0.920
USD/NOK
(-0.05%) $10.67
USD/GBP
(0.08%) $0.788
USD/RUB
(-0.17%) $90.82

Realtime updates for Erytech Pharma SA [ERYP.PA]

Exchange: EURONEXT Industry: Biotechnology
Last Updated28 Jun 2023 @ 11:35
25% discount on Stockinvest.us - Use code: Podcast

0.25% € 0.801

Live Chart Being Loaded With Signals

Commentary (28 Jun 2023 @ 11:35):

ERYTECH Pharma S.A., a clinical-stage biopharmaceutical company, develops red blood cell-based therapeutics for cancer and orphan diseases in France and the United States...

Stats
Today's Volume 27 494.00
Average Volume 215 196
Market Cap 48.66M
EPS €0 ( 2023-09-11 )
Last Dividend €0 ( N/A )
Next Dividend €0 ( N/A )
P/E -80.10
ATR14 €0.0640 (7.99%)

Volume Correlation

Long: 0.27 (neutral)
Short: -0.60 (weak negative)
Signal:(41.547) Neutral

Erytech Pharma SA Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Erytech Pharma SA Correlation - Currency/Commodity

The country flag -0.19
( neutral )
The country flag -0.24
( neutral )
The country flag 0.00
( neutral )
The country flag -0.21
( neutral )
The country flag 0.57
( weak )
The country flag -0.08
( neutral )

Erytech Pharma SA Financials

Annual 2022
Revenue: €0
Gross Profit: €0 (0.00 %)
EPS: €-0.00740
FY 2022
Revenue: €0
Gross Profit: €0 (0.00 %)
EPS: €-0.00740
FY 2021
Revenue: €0.00
Gross Profit: €0.00 (0.00 %)
EPS: €-2.27
FY 2020
Revenue: €0.00
Gross Profit: €-57.58M (0.00 %)
EPS: €-3.65

Financial Reports:

No articles found.

Erytech Pharma SA Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Erytech Pharma SA

ERYTECH Pharma S.A., a clinical-stage biopharmaceutical company, develops red blood cell-based therapeutics for cancer and orphan diseases in France and the United States. Its lead product candidate is eryaspase, which is in Phase 3 clinical development for the treatment of second-line pancreatic cancer, and in Phase 2 stage for the treatment of triple-negative breast cancer and second-line acute lymphoblastic leukemia patients. The company also engages in developing erymethionase, a preclinical product candidate that consists of methionine-?-lyase in red blood cells to target methionine cancers. The company was incorporated in 2004 and is headquartered in Lyon, France.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators